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Highlights 
x Depression and frailty are two common and pervasive conditions in older age. 
x We conducted the first meta-analysis exploring the relationship between these constructs. 
x In cross-sectional studies, participants with frailty had fourfold increased odds of depression. 
x People with depression were at approximately fourfold increased odds of having frailty.   
x Pooled data from longitudinal studies confirmed the heighted risk of comorbidity.   
 
 
ABSTRACT (245/250) 
Aim 
Depression and frailty are prevalent and burdensome in older age. However, the relationships between 
these entities are unclear and no quantitative meta-analysis exists. We conducted a systematic review and 
meta-analysis to investigate the associations between depression and frailty. 
Methods 
Two authors searched major electronic databases from inception until November-2016 for cross-
sectional/longitudinal studies investigating depression and frailty. The strength of the reciprocal 
associations between frailty and depression was assessed through odds ratios (ORs) adjusted for potential 
confounders.   
Results 
From 2306 non duplicated hits, 24 studies were included. The overall prevalence of depression in 8023 
people with frailty was 38.60% (95% CI 30.07 to 47.10, I2=94%). Those with frailty were at increased odds of 
having depression (OR adjusted for publication bias 4.42, 95%CI 2.66-7.35, k=11), also after adjusting for 
potential confounders (OR=2.64; 95%CI: 1.59-4.37, I2=55%, k=4). The prevalence of frailty in 2167 people 
with depression was 40.40% (95%CI 27.00-55.30, I2=97%). People with depression were at increased odds 
of having frailty (OR=4.07, 95%CI 1.93-8.55, k=8). The pooled OR for incident frailty, adjusted for a median 
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of 7 confounders, was 3.72 (95%CI 1.95-7.08, I2=98%, k=4), whilst in two studies frailty increased the risk of 
incident depression with an OR=1.90 (95%CI 1.55-2.32, I2=0%).  
Conclusion 
This meta-analysis points to a reciprocal interaction between depression and frailty in older adults. 
Specifically, each condition is associated with an increased prevalence and incidence of the other, and may 
be a risk factor for the development of the other. However, further prospective investigations are 
warranted.    
Key words: depression, frail, geriatrics, older adults, meta-analysis, psychiatry 
 
INTRODUCTION 
Frailty and depression are two common and pervasive medical conditions among older adults. The 
prevalence of depression in older age ranges from 10-20% (Rodda et al., 2011) and the prevalence of frailty 
is estimated to be similar (Collard et al., 2012). Recent studies have suggested that 16-35 % of frail 
individuals have also experienced co-existing depression, and that the prevalence of depression in frail 
individuals is as high as 46.5% ın older adults (Buigues et al., 2015). Both depression and frailty are 
associated with a range of deleterious outcomes in older age such as lower quality of life (QOL), increased 
use of healthcare services, increased morbidity and mortality (Clegg et al., 2013; Fugate Woods et al., 2005; 
Hare et al., 2014; Rodda et al., 2011). Furthermore, co-existing depression and frailty is associated with 
particularly worse outcomes such as accelerated cognitive impairment and disability (Potter et al., 2016).  
There are several reasons that may account for the high levels of commorbidity between depression and 
frailty. One is the overlap in some areas of diagnostic criteria, e.g. unintentional weight loss, making it 
difficult to distinguish from each other, particularly with advancing age. Another factor one is that 
depression and frailty have some common etiology that makes disentanglement difficult (Brown et al., 
2014). Given the high levels of depression (Buigues et al., 2015) and frailty (Soysal P et al., 2016) in older 
age and the deleterious outcomes when they co-exist, understanding the relationship between these 
factors is of utmost importance.   
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Despite the public health importance, the prevalence and incidence of depression among people with 
frailty and the opposite relationship is largely unknown. The convergence of the frailty and depression 
spectrum in mid- and late-life also give rise to the hypothesis of  ‘overlapping syndromes ’ (Katz, 2004), with 
possible biological mechanisms accounting for both syndromes (Vaughan et al., 2015). Most evidence to 
date suggests that the frailty and depression criteria consist of a highly overlapping but distinct 
subpopulation (Mezuk et al., 2013); moreover, the association between the two constructs cannot be fully 
explained by the overlapping of their symptoms (Lohman, 2013) so frailty and depression must be 
considered interrelated rather than overlapping syndromes. To date, previous narrative and/ or selective 
reviews have suggested there may be a relationship between frailty and depression (Brown et al., 2016; 
Buigues et al., 2015; Mezuk et al., 2012; Benraad et al., 2016; Drey et al.,2011).  For instance, one previous 
narrative systematic review (Vaughan et al., 2015) suggested that the co-occurrence of depression and 
frailty was greater than 10% in older adults ≥ 55 years old, but noted that there is considerable variation in 
the estimates and a meta-analysis was not conducted. To date, to the best of our knowledge, no meta-
analysis has been conducted to consider the relationship between depression and frailty.   
Given the aforementioned, we conducted a systematic review and meta-analysis to investigate 1) the 
prevalence and odds of depression in people with frailty, 2) the prevalence and odds of frailty in people 
with depression, 3) the incidence of depression in people with frailty, and 4) the incidence of frailty in 
people with depression.   
 
MATERIALS AND METHODS 
This systematic review was conducted according to the Strengthening the Reporting of Observational 
Studies in Epidemiology [STROBE] criteria (von Elm et al., 2008) and the recommendations in the Preferred 
Reporting Items for Systematic Reviews and Meta-Analyses [PRISMA] statement (Liberati et al., 2009). The 
review followed a predetermined, but unpublished protocol.   
 
Search strategy 
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Two independent authors (BS and NV) searched Medline (via Ovid), Psychinfo and EMBASE for studies from 
inception until 11/2016 with no language restrictions. The search terms used were (frailty or frail*) and 
(depress* or depressive or major depressive disease).  Conference abstracts were also included and the 
authors were contacted for obtaining missing information at least two times in a month.  
 
Study selection 
Included studies were published quantitative studies of a cross sectional or longitudinal design that: (1) 
Reported the prevalence or incidence of frailty <------> depression in older adults with a mean age over 60 
years and older; (2) Captured frailty with a recognized criteria (e.g. Fried’s criteria (Fried et al., 2001));  (3) 
Captured depression according to structured interview diagnostic criteria (e.g. DSM and major depressive 
disorder (MDD)) or depressive symptoms with a validated depression screening measure (e.g. Center for 
Epidemiologic Studies Depression Scale (CES-D) (Radloff, 1977)) (henceforth called ‘depression’, although 
where possible in the results we differentiate between MDD and depressive symptoms); and (4) included a 
control group (pre-frail and robust as separated entities or together).   
Studies were excluded if they (1) did not use clear diagnostic criteria for frailty or only used one item for its 
diagnosis (e.g. low gait speed) or (2) reported depression with an unvalidated screening tool or measure. 
 
Data extraction 
Two authors (NV, PS) independently extracted data from the selected studies in a standardized Microsoft 
Excel spreadsheet. Any disagreement was resolved by consensus with a third author (BS). The following 
information was extracted: 1) characteristics of the study population (e.g. sample size, demographics, 
country in which the study was performed); 2) setting in which the study was performed; 3) diagnostic 
criteria for frailty and depression; 4) demographic characteristics (mean age and percentage of women) by 
frailty and depression status; 5) type and number of adjustments in the multivariate analyses (for 
longitudinal studies); 6) follow-up period (only for longitudinal studies).  
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If we required additional data to either confirm or enable study inclusion, we contacted the primary 
authors up to three times over a month period.   
 
Outcomes 
The primary outcomes were a) the prevalence and comorbid odds of depression/depressive symptoms in 
frailty and b) the prevalence and comorbid odds of frailty in people with depression/depressive symptoms. 
In addition, we calculated the incidence of c) depression/depressive symptoms onset in people with frailty, 
and d) frailty onset in people with depression/depressive symptoms.   
 
Assessment of study quality 
Study quality was assessed by two investigators (PS, BS) using the Newcastle-Ottawa Scale (NOS) (Wells et 
al., 2012). A third reviewer was available for mediation (NV). The NOS assigns a maximum of 9 points based 
on three quality parameters: selection, comparability, and outcome (Wells et al., 2012).   
 
Statistical analysis 
Analyses were performed by two independent investigators (BS, NV) using Comprehensive Meta-Analysis 
(CMA) 3 (http://www.meta-analysis.com). Due to the anticipated heterogeneity, a random effects meta-
analysis was undertaken. The analyses were conducted in the following steps. First, the prevalence of 
depression among people with frailty together with 95% confidence intervals (CIs) was calculated.  Second, 
the odds ratio and 95% CI of frailty among people with and without depression was calculated. Third, the 
prevalence of frailty among people with depression and 95% CI was calculated. Fourth, the odds ratio and 
95% CI of frailty among people with and without depression was calculated. For each of the above analyses, 
when possible, we conducted subgroup analyses investigating differences according to geographical region, 
study setting, depression classification (structured clinical assessment versus screening measure) and frailty 
measure (e.g. Fried criteria versus others) (Fried et al., 2001)). Where available, adjusted estimates of the 
association between frailty and depression (or the contrary) were extracted and pooled as ORs. Finally, ORs 
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adjusted for the maximum number of covariates available for each study were used to assess the 
association between frailty (or depression) at the baseline and incident depression (or frailty) at follow-up.   
Study heterogeneity was measured using the Cochran’s Q and I-squared statistics, assuming that a p≤0.10 
for the former and a value ≥50% for the latter indicated a significant and substantial heterogeneity (Higgins 
and Thompson, 2002). Given significant heterogeneity, a meta-regression analysis was performed using 
differences in mean age, body mass index (BMI) and percentage of females among groups (frail, pre-frail, 
robust) as moderators in single meta regression. Publication bias was assessed by visually inspecting funnel 
plots, and to account for publication bias, we used the Duval and Tweedie trim-and-fill method (Duval and 
Tweedie, 2000), based on the assumption that the effect sizes of all the studies are normally distributed 
around the center of a funnel plot; in the event of asymmetries, it adjusts for the potential effect of 
unpublished studies.   
 
RESULTS 
The search identified 2,306 non-duplicated potentially eligible studies. Following a detailed review of title 
and abstracts, a total of 63 full text articles were reviewed. The eligibility criteria were applied and 39 
articles were excluded (reasons summarized in Figure 1) with a total of 24 articles meeting the inclusion 
criteria (Almeida et al., 2016, 2015; Arts et al., 2016; Badalà et al., 2008; Brown et al., 2014; Chang et al., 
2010; Collard et al., 2014; de Albuquerque Sousa et al., 2012; Dent and Hoogendijk, 2014; L. Feng et al., 
2014; Fried et al., 2001; Hajek et al., 2016; Jarschik et al., 2012; Jung et al., 2016; Lakey et al., 2012; Lohman 
et al., 2016, 2014; Makizako et al., 2015; McAdams-DeMarco et al., 2016; Monin et al., 2016; Paulson and 
Lichtenberg, 2013; Pegorari and Tavares, 2014; Sanchez-Garcia et al., 2014; Woods et al., 2005). Of the 24 
included studies, 17 studies provided only cross-sectional data, 3 studies provided only longitudinal data, 
and 4 studies had both cross-sectional and longitudinal data. One study (Monin et al., 2016) did not 
contain any data that could be included in the meta-analysis. 
 
 
9 
 
Study and participants’ characteristics 
Study and participants’ characteristics of cross-sectional studies are summarized in Supplementary Tables 
1 and 2. The majority of the studies were conducted among community-dwellers (n = 19 (79.1%)) and in 
North America (n=12 (50.0%)), followed by Europe (n=4), Asia (n=3), Australia (n=3), and Latin America 
(n=2). (Supplementary Table 1). The overall quality of the studies, assessed through NOS, was generally 
good with a median=8 (range=5-9) (Full details are available in Supplementary Table 5). 
Overall 12 cross-sectional studies (Jurschik et al., 2012; Pegorari et al.,2014; Feng, 2014; Matheus et al., 
2015; Dent and Hoogendijk EO, 2014; Chang et al., 2009; Sanchez-Garcìa et  al., 2013; Patricio de 
Albuquerque Sousa et al., 2011; Fried L.P.et al., 2001; Fugate Woods N. et al., 2005; Jung et al., 2016; Mara 
A. McAdams et al., 2016) investigated the prevalence of depression in frailty including a total of 8023 frail 
older participants with a mean age of 74.6 years, of whom 94.0 % were female. These participants were 
compared with 45,775 participants with no frailty (mean age: 70.2; 88.1% females). Furthermore, the 8 
cross sectional studies investigating the prevalence of frailty in people with depression (Collard et al.,2014; 
Lohman et al., 2016; Almeida et al., 2015; Brown  et al., 2015; Lohman et al., 2014; Mezuk et al., 2013; 
Paulson D. and  Lichtenberg, 2013; Osvaldo P. Almeida et al., 2016) included 2,164 depressed older adults 
with a mean age of 69.3 years, 66.5 % of which were females. These subjects were compared with 14,932 
subjects with no depression.  
 
In addition, there were 311 frail older adults in the 3 longitudinal studies (Feng et al., 2014; Makizako et al., 
2015; Monin et al., 2016) (mean age 75.1, 39.1% females) investigating the incidence of depression over a 
mean follow up of 4.67 years. These subjects were compared with 5801 subjects with no frailty at baseline. 
Finally, there were 6404 depressed older adults in 4 longitudinal studies (Fugate Woods N. et al., 2005; 
Paulson and Lichtenberg, 2013; Lakey et al., 2012; A Hajek et al., 2016) that investigated the incidence of 
frailty over a mean follow up of 2.87 years. These participants were compared with 51,610 participants 
with no depression (Supplementary Tables 3 and 4). 
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Measurement of frailty 
Overall, 19 studies used Fried and colleagues’ criteria to define frailty (≥ 3 criteria among unintentional 
weight loss, poor physical activity, slowness, reduced muscular strength, and exhaustion) (Fried et al., 
2001). The other measures of frailty include the Women’s Health Initiative Observational Study (WHI-OS) (≥ 
3 criteria among slowness and exhaustion measured with Rand-36 physical function scale and vital scale 
and self-reported weight loss >5% in the last two years and weekly energy expenditure) (n=1) (Fugate 
Woods N. et al., 2005); International Association of Nutrition and Aging (Iana) Task Force definition of 
frailty (n=2) comprehending five relevant domains: fatigue, resistance, ambulation illnesses and loss of 
weight (≥ 3 criteria) (Abellan et al., 2008); the adapted frailty index including the following: wasting, 
weakness, slowness, fatigue or exhaustion, and falls (n=1) (Paulson and Lichtenberg, 2013); and Clinical 
Frailty Scale ranging from 1 (very fit) to 7 (severely frail) (n=1) (Rockwood et al.,2005).  
 
Measurement of depression 
Depressive symptoms were assessed using the CES-D scale (n=11), the Geriatric Depression Scale (GDS) 
(n=8) (Radloff et al, 1977), and Composite International Diagnostic Interview (CIDI) (n=2) (Wittchen et al., 
1991). Three studies adopted different methods including the Patient Health Questionnaire (PHQ-9) 
(requiring at least 5/9 symptoms) (Kroenke et al., 2001), interview schedule based on the Diagnostic and 
Statistical Manual of Mental Disorders (DSM III-R) and the Burnam 8-item depression screening instrument 
(Burnam et al., 1988). 
 
Cross-sectional meta-analysis findings 
Prevalence of depression in people with frailty 
Full details of the prevalence of depression in people with frailty are summarized in Table 1. The overall 
prevalence of depression in 8023 people with frailty was 38.6% (95% CI 30.07 to 47.10, I2=94%). Table 1 
shows the prevalence of depression in frail people stratified by geographical region, study setting, 
11 
 
depression outcome and definition of frailty. These moderators did not significantly affect our results, 
although the prevalence of frailty was higher in studies in Latin America, among community-dwellers, using 
screening measures for depressive symptoms (instead of structured interviews for MDD) and using the 
criteria suggested by Fried et al. (Table 1). A visual inspection of funnel plots (available from corresponding 
author on request) did not suggest publication bias and the trim and fill analyses all remained unchanged 
when any potential publication bias was adjusted for (Table 1). 
 
Odds of depression in people with frailty versus controls 
Across eleven studies, taking people without frailty as the reference group, frail people had higher odds of 
having comorbid depression (OR=3.95, 95% CI 2.36 to 6.58, p <0.001). After adjusting for publication bias, 
the OR increased to 4.42 (95% CI 2.66-7.35). The between group p values for the subgroup analyses 
remained non-significant (Table 1), however, some results in the subgroups became non-significant which 
may be due to a small number of studies in some groupings.  No study reported the odds of depression in 
people with frailty, adjusted for potential confounders.  
 
Prevalence of frailty in people with depression 
Full details of the meta-analysis of the prevalence of frailty in depression are presented in Table 2. In 2167 
participants with depression, the prevalence of frailty was 40.40% (95% CI 27.00 to 55.30, I2=97%). The 
prevalence of frailty was significantly higher (p=0.03) in studies capturing depression with a screening 
measure (49.50%, 95% CI 32.50 to 66.60) compared to a structured clinical diagnosis for MDD (17.62%, 95% 
CI 5.46 to 44.22) and some variation was noted according to frailty assessment methods, although some 
caution should be given due to small number of studies in each group (Table 2). The trim and fill analyses 
all remained unchanged.   
 
Odds of frailty in people with depression versus controls 
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Taking the participants with no depression as reference, people with depression had an increased risk of 
having frailty (OR=4.07, 95% CI 1.93 to 8.55, p<0.0001; I2=96%) (Table 2). This association was significant in 
five studies including North Americans (OR=2.25; 95%CI 1.00-5.08, p=0.05; I2=96%) compared to other 
settings (Table 2). As shown in Table 2, publication bias was unlikely.  
Four studies (Chang et al., 2010; de Albuquerque Sousa et al., 2012; Jarschik et al., 2012; Pegorari and 
Tavares, 2014) reported the OR for frailty in adjusted analyses in depressed vs. no depressed people, taking 
robust participants as reference. After adjusting for a median of 6 potential confounders (range: 3-12), the 
pooled OR was 2.64 (95%CI: 1.59-4.37; I2=55%; Figure 2). Another study (Jung et al., 2016) reported that an 
OR of 5.25 (95%CI: 2.55-10.83) for frailty vs. pre-frailty/robustness, after adjusting for 4 potential 
confounders.  
 
Longitudinal meta-analysis findings 
Studies investigating incident frailty in older people with depression 
Overall, 6404 older adults with depression at baseline were followed over a mean of 2.87 years 
investigating incident frailty (Fugate Woods N. et al., 2005; Paulson and Lichtenberg, 2013; Lakey et al., 
2012; A Hajek et al., 2016). The pooled OR for incident frailty, adjusted for a median of 7 potential 
confounders (range: 0-21) (Supplementary Table 3), was 3.72 (95%CI 1.95-7.08; p<0.0001; I2=98%), as 
shown in Figure 3.   
 
Studies investigating incident depression among people with frailty 
Overall, two longitudinal studies (L. L. Feng et al., 2014; Makizako et al., 2015) including 4852 older adults 
investigated incident depression as the outcome. These two studies found that frailty at the baseline 
increased the risk of incident depression by about 90% (OR=1.90; 95%CI 1.55-2.32, p<0.0001; I2=0%), after 
adjusting for 11 covariates (Figure 4; Supplementary Table 4). One study (Monin et al., 2016) with no meta-
analyzable data reported an association between depression and frailty in 1260 community-dwelling 
married couples.  
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DISCUSSION 
In this meta-analysis, for the first time, we have considered the possible bidirectional relationship between 
frailty and depression summarizing the data of both cross-sectional and longitudinal studies. In summary, 
our data suggests that across cross-sectional studies, approximately forty percent of individuals with 
depression have frailty and a similar proportion of those with frailty have depression. Our comparative 
meta-analysis suggests that frail older people are four times more likely to have depression than non-frail 
people. A similar increased odds for frailty was evident in older people with depression versus those 
without depression. Longitudinal studies substantially confirmed these findings despite being more limited 
in number.  
 
Frailty, is a multifactorial geriatric syndrome, which could be influenced by pain, mobility and balance 
problems, weakness, poor endurance etc. All of these risk factors may lead to disability, or functional 
dependence, and thus lead to depression (Fugate Woods N. et al., 2005). On the other hand, depression 
may also predict indicators of frailty due to the decrease in social ties, gait speed, and less physical 
activities, or due to the increase in sedentary life, fall risk, weight loss, and malnutrition, which may 
increase the perpetuation of affective symptoms typical of depression including sadness, anhedonia, and 
helplessness (A Hajek et al., 2016; Paulson et al., 2013). Additionally, depression may not only be associated 
with physical frailty, but also with cognitive impairment, which may be long-lasting and may persist even 
during affective remission (Bortolato et al., 2016). Depression-related cognitive impairment may contribute 
to the emergence of frailty. It is also possible that there are shared risk factors and pathophysiological 
pathways. First, these reciprocal associations may be at least partly explained by overlapping mechanisms 
such as cerebrovascular disease, chronic inflammation, oxidative stress (Black et al., 2015), mitochondrial 
dysfunction (Brown et al., 2016), hypothalamic-pituitary-adrenal (HPA) axis dysregulation (Belvederi et al., 
2014), among others (Katz, 2004; Soysal et al., 2016; Soysal P et al., 2017). Subclinical vascular diseases that 
cause pre-frontal white-matter hyperintensities in patients with late-life depression have consistently been 
considered a key factor in prefrailty (Newberg et al., 2006). Growing evidence also supports a positive 
association between frailty and the inflammatory cytokines, such as interleukin 6 (IL 6) (Soysal et al., 2016), 
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which is also known to be elevated in individuals with late life depression (Vaughan et al., 2015). 
Inflammatory cytokines are associated with both decreased muscle mass and strength, and also negatively 
affect the central dopaminergic function, which may result in depressive affect, fatigue, and cognitive and 
motor slowing (Brown et al., 2016). Mitochondrial dysfunction has also been identified in numerous 
neurodegenerative diseases as well as depression. Muscle biopsies in patients with depression have shown 
decreased ATP production, and adults with depression had also impaired mitochondrial respiration in 
peripheral blood mononuclear cells, most strongly correlating with the symptom of fatigue (Brown et al., 
2016). The detrimental cycle between declined activity, mobility, and energy levels resembles the clinical 
presentation of depression as well as those with the frailty syndrome (Brown et al., 2016). Another 
hypothesis is that HPA axis dysregulation, as well as aberrations in other mediators, such as insulin-like 
growth factor, and testosterone (Belvederi et al., 2014), have been reported in frail persons with significant 
depressive symptoms and may account for the reciprocal association herein observed (von Zerssen et al., 
1986). Moreover, the beneficial effects of the approaches to prevent frailty or depression may protect the 
other. For example, the successful treatment of the depression itself may result in increased behavioral and 
social activation, thereby increasing physical and social activity levels, improving muscle mass and strength, 
and the elder’s overall energy levels, thereby, reducing frailty (Lakey et al., 2012). Similarly, increasing 
physical activity is an effective intervention for frailty in older adults, and can protect and manage 
depressive symptoms in the elderly through potential neurobiological changes and as a consequence of 
social and physical engagement (Brown et al., 2016; Stieglitz et al, 2014; Peterson et al., 2009; Schuch et 
al.,2016a; Schuch et al., 2016b). Other interventions such as improving balance and muscle strength, and 
vitamin D supplementation may also play a role in preventing or treating frailty (Brouwer-Brolsma et al., 
2013). Depressive symptoms may cause vitamin D deficiency via decreased sun exposure, poorer dietary 
intake and more smoking (Brouwer-Brolsma et al., 2013). In fact, all these findings support the 
bidirectionality of the depression–frailty relationship. Clearly, future research is required to explore and 
understand such relationships.   
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Our comprehensive meta-analysis results advance the literature from previously published narrative and/ 
or selective reviews that have considered the relationship between depression and frailty. Meta-analyses 
enable the logical pooling of data and enable a more precise estimate of the prevalence and/ or odds of an 
outcome than when making subjective considerations of individual studies separately such as those in 
previous narrative reviews (Ioannidis and Lau, 1999). Nonetheless, the previous reviews have illustrated 
some interesting findings. One review, including 28 studies, reported that frailty and depression are 
comorbid geriatric syndromes in a subgroup of older individuals, and that frailty is also a risk factor for the 
development and persistence of depressive symptoms (Buigues et al., 2015). Another review, including 
both cross-sectional (n = 16) and cohort studies (n = 23) indicated that frailty, its components, and 
functional impairment are risk factors for depression (Mezuk et al., 2012). On the other hand, another 
review found that the relationship between depressive symptomatology and increased risk of incident 
frailty was robust, while the opposite relationship was less conclusive (Vaughan et al., 2015). However, the 
potential role of antidepressant medications on frailty has not been clearly evaluated in any of these 
reviews. Because, as shown in the review by Benraad et al, geriatric characteristics are rarely taken into 
account in trials on antidepressant drugs in late-life depression (Benraad et al., 2016). To differentiate from 
these previous reviews, the meta-analysis was performed in the present study (Buigues et al., 2015; Mezuk 
et al., 2012). Specifically our data established that frail older people are four times more likely to have 
depression compared to controls, with similar increased odds for frailty among those with depression 
versus controls. While cross-sectional studies are unable to clarify the directionality of the relationship 
between frailty and depression, it clearly indicates that there is a high level of comorbidity.  Whether or not 
this is attributed to mutually exclusive or overlapping symptomology of each condition is not clear and 
future prospective research may help to disentangle this relationship and explore potential overlapping 
symptomology and disease onset. Nonetheless, the limited number prospective studies does suggest that 
after adjusting for confounders, people with depression are at increased risk of developing frailty, whilst 
the converse relationship also appears to be evident. However, the small number of longitudinal studies 
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precludes any definitive conclusions and future longitudinal research is required to specifically attempt to 
differentiate between the signs and symptoms of both conditions.   
 
Some factors were identified in our analyses as being potentially important in explaining the association 
between depression and frailty. The prevalence of depression in frail people, in fact, was higher in studies 
from Latin America, among community-dwellers, those using depression screening measures (instead 
structured interviews) and in studies which considered criteria suggested by Fried et al. (Fried et al., 2001) 
A recent international study demonstrated that depressive symptoms are more pronounced within 
traditional family based value patterns, like Latin America, possibly because of higher expectations of the 
availability of family support that are often only partially fulfilled due to recent changes in family structure 
(Ylli et al 2016). Fried’s criteria shares symptoms with the CES-D and this could partially explain the high 
correlation. However, some studies have found that the strong association between frailty and depression 
is not unique to a single definition of frailty such as the Clinical Frailty Index, and thus, our findings do not 
seem to be fully explained by shared symptomatology (Lohman et al., 2014). We also examined the 
opposite relationship, i.e. the prevalence of depression among the frail and the odds and incidence of 
depression in frail older individuals compared to robust ones. Depressed people showed significantly higher 
levels of frailty (~40%), mainly in North American studies and in one Australian study (Almedia et al., 2015).   
 
Prospective studies of the relationship between depression and incident frailty also suggest that depression 
may increase the risk of frailty (Vaughan et al., 2015). Depression is associated with increased weakness, 
mobility deficits, and fatigue, which may thus increase the risk of frailty and increased mortality over a 
period of up to 5 years (Veronese et al., 2016). The role of antidepressant drug treatment in the 
relationship between depression and frailty deserve further investigation. Antidepressants have been 
associated with a higher risk of incident frailty (Lakey et al., 2012). This association could simply be 
explained by a more severe and chronic form of depression that required the use of antidepressant drugs 
(Vaughan et al., 2015), but a large prospective observational study reported that even in the absence of 
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depressive symptoms, antidepressant use was associated with becoming frail (Lakey et al., 2012). 
Therefore, non-pharmacological interventions may be an important approach for depressed frail older 
adults. Clearly further research is needed to elucidate the possible role of drugs in the depression-frailty 
relationship (Mezuk et al., 2012). 
 
LIMITATIONS 
Whilst our data provides some novel insights, some limitations should be acknowledged. The most 
important lies in that the evidence is largely drawn from case-control and cross-sectional studies. Thus the 
directionality and degree of overlap between these two constructs is not clear. In addition, the number of 
prospective studies was limited, therefore future prospective research is required to allow a better 
elucidation of potential moderators which could influence the reciprocal prospective associations between 
depression and frailty. A second limitation is the high heterogeneity observed. The different methods and 
different cut-off values used for defining frailty and depression might play a role, but our findings suggest 
that these factors cannot completely explain the observed reciprocal associations. Third, there was limited 
information on important moderators such as physical activity, medication use, presence of dementia, and 
inflammatory cytokines. Fourth, depression was diagnosed through non-original methods (DSM), and only 
four studies (Anand et al., 2012; L. Feng et al., 2014; Fried et al., 2001; Lakey et al., 2012) reported data 
regarding antidepressants, thus precluding the possibility to conduct a meta-analysis. However, in one large 
longitudinal study, the use of antidepressants was associated with a higher incidence of frailty indicating 
that this factor is of importance in the association between depression and frailty (Lakey et al., 2012).  Thus, 
future research should consider the relationship between antidepressant medication and 
frailty/depression. Finally, the presence of depressive symptoms in the construct of frailty may artificially 
contribute to the relationship between frailty and depression. More research is required to investigate the 
relationship between major depression and clearly defined frailty in particular. Such research might also 
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consider the relationship of important potential moderators such as physical activity, antidepressant 
medication and inflammatory markers.   
In conclusion, our results provide evidence for a consistent bidirectional relationship between frailty and 
depression among older people. However, the precise mechanisms underpinning those reciprocal 
epidemiological associations deserve further investigation. Our data suggest that over a third of people 
with frailty have depression and a similar proportion of people with depression have frailty, while the odds 
of each condition are four times higher than controls. Therefore, interventions designed to decrease one of 
both syndromes can prevent the emergence of other. Our data is of public health importance and may 
open important perspectives for the prevention and treatment of those highly co-occurring and prevalent 
conditions.   
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Figure 1. PRISMA flow-chart 
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Figure 2. Odds of frailty in people with depression versus controls 
 
Figure 3. Odds  for incident frailty in older people with depression 
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Figure 4. Odds for incident depression among people with frailty 
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Table 1-Meta-analysis results of prevalence and odds of depression in older people with frailty  
Analysis Number 
of study 
estimates 
Number 
of 
participan
ts 
Meta-analysis Between 
group p value 
Trim and fill effect size 
(95% CI) [adjusted studies] 
I2 
Prevalence of depression in older people with frailty 
   Prevalence 95% CI    
Main analysis 11 8023 38.60% 30.07 47.10  Unchanged 94 
Geographical region      0.751   
North America 5 7478 41.08% 29.02 54.31  Unchanged 97 
Asia 2 211 34.63% 17.57 56.83  N/A 46 
Europe 2 147 30.12% 14.93 51.44  N/A N/A 
Latin America 2 190 44.02% 24.78 65.24  N/A N/A 
Study Setting      0.737   
Community 10 7830 39.00% 30.05 48.13  Unchanged 94 
Community and inpatients 1 96 34.02% 13.84 62.32  N/A N/A 
Depression outcome      0.737   
Screening measure 10 7830 39.00% 30.05 48.13  Unchanged 94 
Structured instrument 1 96 34.02% 13.84 62.32  N/A N/A 
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Frailty measure      <0.001   
Fried 10 1302 40.04% 33.60 47.60  Unchanged 83 
WHI-OS 1 6619 26.16% 12.98 45.70  N/A N/A 
Odds of depression in older people with frailty 
 OR 95% CI    
Main analysis 11 53626 3.94 2.36 6.58 <0.001 4.42 (2.66-7.35) [1] 96 
Geographical region      0.312   
North America 5 49181 6.700 2.92 15.34 <0.001 Unchanged  98 
Asia 2 2207 4.582 1.24 18.92 0.02 N/A 69 
Europe 2 889 1.298 0.23 7.12 0.763 N/A N/A 
Latin America 2 1349 2.437 0.45 13.12 0.299 N/A N/A 
Study Setting      0.28   
Community 10 53260 4.420 2.57 7.65 <0.0001 4.99 (2.93-8.51) [1] 96 
Outpatients and inpatients 1 366 1.240 0.24 6.20 0.86 N/A N/A 
Depression outcome      0.28   
Screening measure 10 53260 4.420 2.57 7.65 <0.0001 4.99 (2.93-8.51) [1] 96 
Structured instrument 1 366 1.240 0.24 6.20 0.86 N/A N/A 
Frailty measure      0.34   
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Key: 
N/A= 
not 
appli
cable.   
CI: Confidence interval; OR: Odds ratio; WHI-OS: Women's Health Initiative Observational Study - 
 
 
  
Fried 10 12969 4.074 1.96 8.84 0.001 4.65 (2.30-9.38) [1] 96 
WHI-OS 1 40657 2.855 0.28 28.69 0.372 N/A N/A 
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Table 2-Meta-analysis results of prevalence and odds of frailty in older people with depression  
Analysis Number 
of study 
estimates 
Number 
of 
participan
ts 
Meta-analysis Between 
group p value 
Trim and fill effect size 
(95% CI) [adjusted studies] 
I2 
Prevalence of frailty in older people with depression 
   Prevalence 95% CI    
Main analysis 8 2167 40.40% 27.00 55.30  Unchanged 97 
Geographical region      0.027   
North America 5 1381 31.26% 17.32 49.67  Unchanged 97 
Australia 2 398 72.9% 39.1 91.9  N/A N/A 
Europe 1 378 27.24% 0.64 67.38  N/A N/A 
Study setting      0.576   
Community 7 1789 42.60% 27.10 59.70  Unchanged 97 
Community and inpatient 1 378 27.24% 5.450 70.86  N/A N/A 
Depression classification      0.03   
Screening tool 6 1701 49.50% 32.50 66.60  Unchanged 97 
Structured interview 2 466 17.62% 5.460 44.22  N/A 90 
Frailty measure      0.007   
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Fried 5 1592 27.12% 15.9 49.29  Unchanged 96 
Fried adapted 1 167 51.49% 20.04 81.80  N/A N/A 
Iana Task 2 408 85.45% 54.31 96.67  N/A N/A 
Odds of frailty in older people with depression 
 OR 95% CI    
Main analysis 8 17099 4.068 1.93 8.55 <0.001 Unchanged 96 
Geographical region      0.063   
North America 5 9185 2.256 1.00 5.08 0.05 Unchanged 96 
Australia 2 7404 19.35 3.91 95.76 <0.001 N/A 93 
Europe 1 510 3.745 0.573 24.48 0.168 N/A N/A 
Study setting      0.675   
Community 7 16589 4.11 1.82 9.28 0.001 Unchanged 97 
Community and inpatient 1 510 3.74 0.42 33.31 0.23 N/A N/A 
Depression classification      0.655   
Screening tool 6 15906 4.60 1.93 11.80 0.001 Unchanged 96 
Structured interview 2 1193 2.67 0.55 12.78 0.29 N/A N/A 
Frailty measure      0.056   
Fried 5 11680 2.18 0.93 5.09 0.09 Unchanged 95 
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Key: 
N/A= 
not 
appli
cable.   
CI: Confidence interval; OR: Odds ratio 
 
Fried adapted 1 580 4.22 0.60 29.34 0.145 N/A N/A 
Iana Task 2 4839 19.12 1.23 16.13 <0.001 N/A N/A 
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